KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) FCF Payout Ratio (2016 - 2026)

Gsk has reported FCF Payout Ratio over the past 18 years, most recently at 0.41 for Q1 2026.

  • For Q1 2026, FCF Payout Ratio fell 0.92% year-over-year to 0.41; the TTM value through Mar 2026 reached 0.14, down 21.03%, while the annual FY2025 figure was 0.4, 15.41% down from the prior year.
  • FCF Payout Ratio for Q1 2026 was 0.41 at Gsk, down from 0.14 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 0.02 in Q3 2023 and troughed at 16.73 in Q4 2022.
  • A 5-year average of 1.29 and a median of 0.11 in 2025 define the central range for FCF Payout Ratio.
  • Biggest five-year swings in FCF Payout Ratio: tumbled 17911.56% in 2022 and later soared 99.45% in 2023.
  • Year by year, FCF Payout Ratio stood at 16.73 in 2022, then soared by 99.45% to 0.09 in 2023, then surged by 51.23% to 0.04 in 2024, then tumbled by 207.83% to 0.14 in 2025, then plummeted by 198.44% to 0.41 in 2026.
  • Business Quant data shows FCF Payout Ratio for GSK at 0.41 in Q1 2026, 0.14 in Q4 2025, and 0.04 in Q3 2025.